Honeywell International Inc vs Medpace Holdings Inc — how do they compare? Honeywell International Inc trades at $229.24 (market cap $71.66B), while Medpace Holdings Inc trades at $530.22 (market cap $15.08B). The key difference: Honeywell International Inc is far larger — about 4.8× Medpace Holdings Inc's market cap, and Honeywell International Inc pays a 4.21% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| HON | MEDP | |
|---|---|---|
Market Cap | $71.66B | $15.08B |
Sector | Industrials | Technology |
52-Week High | $248.04 | $620.59 |
52-Week Low | $188.14 | $308.88 |
Enterprise Value | $96.01B | $14.55B |
Dividend Yield | 4.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →